SCHEMBL18409102

SCHEMBL18409102

CCc1cc(CNC(=O)C(F)F)c(F)cc1Nc1cc2c(ncn2C)c(N(Cc2ccc(OC)cc2OC)C(=O)C2CC2)n1

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.33
ALDH1A1 P00352 2/20 0.33
TSHR P16473 2/20 0.33
NPSR1 Q6W5P4 1/20 0.32
PPARG P37231 1/20 0.32
MAPT P10636 1/20 0.32
EPHX2 P34913 3/20 0.32
JAK2 O60674 1/20 0.32
JAK1 P23458 1/20 0.32
TYK2 P29597 1/20 0.32
JAK3 P52333 1/20 0.32
CTSD P07339 2/20 0.31
CCRL2 O00421 1/20 0.31
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
MTNR1A P48039 1/20 0.31
MTNR1B P49286 1/20 0.31
TTK P33981 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18409283 0.88 JAK2 (0.34) LMNAALDH1A1TSHRNPSR1PPARG
SCHEMBL18409113 0.86 ALDH1A1 (0.36) ALDH1A1NPSR1PPARGMAPTKMT2A
SCHEMBL18409110 0.83 POLB (0.33) LMNAALDH1A1TSHRPPARGJAK2
SCHEMBL18409291 0.81 JAK2 (0.37) ALDH1A1JAK2JAK1TYK2JAK3
SCHEMBL18409360 0.80 MEN1 (0.36) LMNAALDH1A1NPSR1MAPTKMT2A
SCHEMBL18409164 0.80 JAK2 (0.42) LMNAALDH1A1TSHRJAK2JAK1
SCHEMBL18409541 0.79 PIK3CA (0.35) LMNAALDH1A1TSHRMAPTJAK2
SCHEMBL18409180 0.79 TYK2 (0.35) LMNAALDH1A1TSHRNPSR1MAPT
SCHEMBL18409277 0.79 JAK2 (0.37) JAK2JAK1TYK2JAK3
SCHEMBL18409116 0.78 JAK2 (0.38) ALDH1A1JAK2JAK1TYK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 WO disclosed